Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Current Leases (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Current Leases for 3 consecutive years, with $275000.0 as the latest value for Q3 2024.

  • Quarterly Current Leases rose 12.7% to $275000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $275000.0 through Sep 2024, up 12.7% year-over-year, with the annual reading at $251000.0 for FY2023, 80.58% up from the prior year.
  • Current Leases for Q3 2024 was $275000.0 at Spruce Biosciences, up from $267000.0 in the prior quarter.
  • The five-year high for Current Leases was $380000.0 in Q2 2022, with the low at $139000.0 in Q4 2022.
  • Average Current Leases over 3 years is $265000.0, with a median of $255000.0 recorded in 2023.
  • Peak annual rise in Current Leases hit 80.58% in 2023, while the deepest fall reached 38.11% in 2023.
  • Over 3 years, Current Leases stood at $139000.0 in 2022, then soared by 80.58% to $251000.0 in 2023, then grew by 9.56% to $275000.0 in 2024.
  • According to Business Quant data, Current Leases over the past three periods came in at $275000.0, $267000.0, and $259000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.